| Date Checked | 2025-12-21 23:39:18 |
|---|
| Graham Number | (PB)40.43 vs (PE)52.05 |
|---|
| Over / Under Value Percentage | 233.79% vs 205.05% |
|---|
| Dividend Yield | 1.58% |
|---|
| Dividend Date | 2025-12-02 |
|---|
| Symbol | ZTS |
|---|
| AssetType | Common Stock |
|---|
| Name | Zoetis Inc |
|---|
| Description | Zoetis Inc. (ZTS) is a leading global animal health company dedicated to improving the health and well-being of livestock and companion animals. As the largest manufacturer of medicines and vaccines for animals, Zoetis leverages advanced research and development to offer a comprehensive range of innovative products that enhance productivity in animal agriculture and support the well-being of pets globally. Committed to sustainability and animal welfare, Zoetis is well-positioned to meet the increasing demand for premium animal health solutions in an expanding market, making it an attractive investment opportunity for institutional investors. |
|---|
| CIK | 1555280 |
|---|
| Exchange | NYSE |
|---|
| Currency | USD |
|---|
| Country | USA |
|---|
| Sector | HEALTHCARE |
|---|
| Industry | DRUG MANUFACTURERS - SPECIALTY & GENERIC |
|---|
| Address | 10 SYLVAN WAY, PARSIPPANY, NJ, UNITED STATES, 07054 |
|---|
| OfficialSite | https://www.zoetis.com |
|---|
| FiscalYearEnd | December |
|---|
| LatestQuarter | 2025-09-30 |
|---|
| MarketCapitalization | 53363724000 |
|---|
| EBITDA | 3991000000 |
|---|
| PERatio | 20.27 |
|---|
| PEGRatio | 2.336 |
|---|
| BookValue | 12.23 |
|---|
| DividendPerShare | 1.932 |
|---|
| EPS | 5.94 |
|---|
| RevenuePerShareTTM | 21.04 |
|---|
| ProfitMargin | 0.282 |
|---|
| OperatingMarginTTM | 0.393 |
|---|
| ReturnOnAssetsTTM | 0.151 |
|---|
| ReturnOnEquityTTM | 0.499 |
|---|
| RevenueTTM | 9397000000 |
|---|
| GrossProfitTTM | 6741000000 |
|---|
| DilutedEPSTTM | 5.94 |
|---|
| QuarterlyEarningsGrowthYOY | 0.085 |
|---|
| QuarterlyRevenueGrowthYOY | 0.005 |
|---|
| AnalystTargetPrice | 165.36 |
|---|
| AnalystRatingStrongBuy | 5 |
|---|
| AnalystRatingBuy | 8 |
|---|
| AnalystRatingHold | 6 |
|---|
| AnalystRatingSell | 0 |
|---|
| AnalystRatingStrongSell | 0 |
|---|
| TrailingPE | 20.27 |
|---|
| ForwardPE | 18.9 |
|---|
| PriceToSalesRatioTTM | 5.68 |
|---|
| PriceToBookRatio | 10.16 |
|---|
| EVToRevenue | 6.39 |
|---|
| EVToEBITDA | 14.87 |
|---|
| Beta | 0.962 |
|---|
| 52WeekHigh | 179.46 |
|---|
| 52WeekLow | 115.25 |
|---|
| 50DayMovingAverage | 134.95 |
|---|
| 200DayMovingAverage | 151.53 |
|---|
| SharesOutstanding | 440693000 |
|---|
| SharesFloat | 439829000 |
|---|
| PercentInsiders | 0.100 |
|---|
| PercentInstitutions | 97.690 |
|---|
| ExDividendDate | 2025-10-31 |
|---|
| dateChecked | 2025-12-21 23:39:18 |
|---|
| fresh | 1 |
|---|